AU2002220025A1 - Rotavirus enterotoxin NSP4 and methods of using same - Google Patents

Rotavirus enterotoxin NSP4 and methods of using same

Info

Publication number
AU2002220025A1
AU2002220025A1 AU2002220025A AU2002502A AU2002220025A1 AU 2002220025 A1 AU2002220025 A1 AU 2002220025A1 AU 2002220025 A AU2002220025 A AU 2002220025A AU 2002502 A AU2002502 A AU 2002502A AU 2002220025 A1 AU2002220025 A1 AU 2002220025A1
Authority
AU
Australia
Prior art keywords
nsp4
peptide
nucleic acid
protein
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002220025A
Other languages
English (en)
Inventor
Judith M. Ball
Mary K. Estes
Peng Tian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/705,621 external-priority patent/US6673355B1/en
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU2002220025A1 publication Critical patent/AU2002220025A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002220025A 2000-11-03 2001-11-02 Rotavirus enterotoxin NSP4 and methods of using same Abandoned AU2002220025A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/705,621 US6673355B1 (en) 1995-06-14 2000-11-03 Rotavirus enterotoxin NSP4 and methods of using same
US09/705,621 2000-11-03
PCT/US2001/045255 WO2002036172A2 (fr) 2000-11-03 2001-11-02 Enterotoxine nsp4 de rotavirus et ses methodes d'utilisation

Publications (1)

Publication Number Publication Date
AU2002220025A1 true AU2002220025A1 (en) 2002-05-15

Family

ID=24834264

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002220025A Abandoned AU2002220025A1 (en) 2000-11-03 2001-11-02 Rotavirus enterotoxin NSP4 and methods of using same

Country Status (4)

Country Link
EP (1) EP1349571A4 (fr)
AU (1) AU2002220025A1 (fr)
CA (1) CA2427809A1 (fr)
WO (1) WO2002036172A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1576877A1 (fr) * 2004-03-04 2005-09-21 Bioprotein Technologies Production de protéines recombinantes de rotavirus dans le lait d'animaux transgéniques non-humains
EP2360175B1 (fr) * 2005-11-22 2014-07-16 Novartis Vaccines and Diagnostics, Inc. Particules de type virus (vlps) de norovirus et de sapovirus
HUE033858T2 (en) * 2012-02-14 2018-01-29 Merial Inc Rotavirus unit vaccines and method for their preparation and use
CN104661675B (zh) * 2012-05-16 2019-04-30 阿德莱德研究创新私人有限公司 细胞疫苗和诱导受试者免疫反应的方法
JP6841762B2 (ja) * 2015-01-23 2021-03-10 メディカゴ インコーポレイテッド 植物中でのロタウイルス様粒子産生
CN108504718A (zh) * 2018-03-27 2018-09-07 东莞市第三人民医院 一种CaSR在RV、NSP4感染后的表达水平分析方法
CN117866858A (zh) * 2023-11-30 2024-04-12 吉林农业大学 一种表达猪轮状病毒抗原的重组植物乳杆菌及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5186933A (en) * 1986-12-30 1993-02-16 Baylor College Of Medicine Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
US5298244A (en) * 1990-10-25 1994-03-29 University Of Saskatchewan Assembled viral particles and their use in a vaccine to rotaviral disease
ATE248601T1 (de) * 1995-06-14 2003-09-15 Baylor College Medicine Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4
WO2001027335A1 (fr) * 1999-10-14 2001-04-19 Baylor College Of Medicine Adjuvant
FR2806087B1 (fr) * 2000-03-07 2002-10-18 Agronomique Inst Nat Rech Particules pseudovirales de rotavirus et leur utilisation pour vectoriser des proteines ou des acides nucleiques

Also Published As

Publication number Publication date
EP1349571A2 (fr) 2003-10-08
WO2002036172A2 (fr) 2002-05-10
WO2002036172A3 (fr) 2002-09-19
EP1349571A4 (fr) 2005-02-16
CA2427809A1 (fr) 2002-05-10

Similar Documents

Publication Publication Date Title
Dalsgaard et al. Plant–derived vaccine protects target animals against a viral disease
US5690938A (en) Oral immunization with multiple particulate antigen delivery system
Horie et al. Diarrhea induction by rotavirus NSP4 in the homologous mouse model system
US20220313812A1 (en) Senecavirus a immunogenic compositions and methods thereof
US6673355B1 (en) Rotavirus enterotoxin NSP4 and methods of using same
KR20190110605A (ko) 돼지 코로나바이러스 백신
NO341881B1 (no) Polypeptid, protein, metode for fremstilling av salmonid alphavirus nøytraliserende antistoffer, nukleinsyre, bærer, vaksine og diagnostisk sett
US8685411B2 (en) Rotavirus antigens
JP2023544396A (ja) ロタウイルスに対するワクチン接種のために有用な融合タンパク質
JPH06504190A (ja) アセンブルしたウイルス粒子およびロタウイルス疾患ワクチンにおけるその使用
US6210682B1 (en) Rotavirus enterotoxin NSP4 and methods of using same
AU2002220025A1 (en) Rotavirus enterotoxin NSP4 and methods of using same
CN108431214B (zh) 人轮状病毒g9p[6]毒株和作为疫苗的用途
US20030175303A1 (en) Production method of recombinant rotavirus structural proteins and vaccine composition
Viaplana et al. Antigenicity of VP60 structural proteinof rabbit haemorrhagic disease virus
KR20120066555A (ko) 돼지 유행성 설사병 바이러스의 에피토프 단백질을 발현하는 형질전환체 및 이를 포함하는 ｐｅｄｖ 백신 조성물
WO2004009115A1 (fr) Sous-unite vp6 de rotavirus
AU768605B2 (en) Rotavirus enterotoxin NSP4 and methods of using same
US20240050555A1 (en) Immunogenic composition useful for vaccination against rotavirus
JP2023544403A (ja) サーコウイルス科カプシドタンパク質を含む融合タンパク質、及びそれから構成されるキメラウイルス様粒子
WO1989006971A1 (fr) Segments de genes de rotavirus conserves et utilisation de tels segments dans des techniques d'immunisation et de neutralisation
CN117959420A (zh) 一种猪流行性腹泻病毒二价亚单位疫苗及制备方法
Ren Epitope mapping of the non-structural protein 2 (NSP2) of rotavirus
Both et al. Analysis of Rotavirus Proteins by Gene Cloning, Mutagenesis, and Expression
Kim Detection of group C Rotaviruses in Feeder Pigs, production of group a/c rotavirus-like particles (VLPS) and use of group A VLP Vaccines in cattle

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application